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Abstract
Introduction: There have been very few randomized clinical trials of interventions for alcohol use disorders (AUD) in people
living with HIV (PLWH) in African countries. This is despite the fact that alcohol use is one of the modifiable risk factors for
poor virological control in PLWH on antiretroviral therapy.
Methods: Sixteen clinic clusters in Zimbabwe were selected through stratified randomization and randomized 1: 1 to Intervention
and Control arms. Inclusion criteria for individual participants were being adult, living with HIV and a probable alcohol use disorder
as defined by a score of 6 (women) or 7 (men) on the Alcohol Use Disorders Identification Test (AUDIT). In the Intervention clus-
ters, participants received 8 to 10 sessions of Motivational Interviewing blended with brief Cognitive Behavioural Therapy (MI-
CBT). In the control clusters, participants received four Enhanced Usual Care (EUC) sessions based on the alcohol treatment mod-
ule from the World Health Organisation mhGAP intervention guide. General Nurses from the clinics were trained to deliver both
treatments. The primary outcome was a change in AUDITscore at six-month post-randomization. Viral load, functioning and quality
of life were secondary outcomes. A random-effects analysis-of-covariance model was used to account for the cluster design.
Results: Two hundred and thirty-four participants (n = 108 intervention and n = 126 control) were enrolled across 16 clinics.
Participants were recruited from November 2016 to November 2017 and followed through to May 2018. Their mean age
was 43.3 years (SD = 9.1) and 78.6% (n = 184) were male. At six months, the mean AUDIT score fell by 6.15 (95% CI
6.32; 6.00) in the MI-CBT arm, compared to a fall of  3.09 95 % CI  3.21; 2.93) in the EUC arm (mean difference
3.09 (95% CI 4.53 to 1.23) (p = 0.05). Viral load reduced and quality of life and functioning improved in both arms but
the difference between arms was non-significant.
Conclusions: Interventions for hazardous drinking and AUD comprising brief, multiple alcohol treatment sessions delivered by
nurses in public HIV facilities in low-income African countries can reduce problematic drinking among PLWH. Such interven-
tions should be integrated into the primary care management of AUD and HIV and delivered by non-specialist providers.
Research is needed on cost-effectiveness and implementation of such interventions, and on validation of cut-points for alcohol
use scales in low resource settings, in partnership with those with lived experience of HIV and AUD.
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1 | INTRODUCTION
For people living with HIV, Alcohol Use Disorders (AUD) are
highly prevalent and increase the likelihood of risky sexual prac-
tices, poor engagement in HIV care, viral non-suppression and
liver damage [1-4]. Out of the 34 million people living with HIV
(PLWH) worldwide, 68% live in sub-Saharan Africa (SSA) [5].
Among PLWH in SSA, a recent meta-analysis estimated the
prevalence of AUD to range between 12% and 62% [6]. Binge
drinking is more frequent in PLWH living in SSA than in the gen-
eral population [7]. All these findings point to the need for
research on interventions to reduce alcohol use in PLWH living
in SSA.
AUD treatment involves screening and provision of psy-
chosocial interventions, with or without pharmacological thera-
pies. In high-income countries, several psychological
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interventions are used for AUD including Motivational Inter-
viewing (MI) alone or with cognitive behavioural therapy
(CBT), stress management, problem solving, case management
and community contingency therapy [8-10]. Until recently,
however, there has been little evidence that any of these
interventions have beneficial effects on AUD in PLWH. MI,
plus personalized feedback on the level of alcohol intake and
its potential harm to the individual showed promise in two
studies in the United States [8,9]. Given the shortage of psy-
chologists in low- and middle-income countries (LMICs), the
World Health Organisation (WHO) developed the Mental
Health Gap Intervention Guide (mhGAP IG) [11]. All the inter-
ventions in the WHO mhGAP IG are evidence-based and can
be delivered by non-specialists. The WHO mhGAP IG recom-
mends brief (one-session) psychoeducation for AUD in general
primary care. However, there is a dearth of research on
mhGAP interventions for PLWH in SSA.
Until 2020 there had only been five published randomized
controlled trials (RCT) of interventions for AUD in PLWH in
SSA [10,12-15] all with limitations. One evaluated a four-ses-
sion intervention in a small sample of women [10]. Another
compared six sessions of CBT with usual care but the sam-
ple size was small (n = 75 and the follow-up period relatively
short (90 days) [13]. Another found a 20-session intervention
reduced alcohol-use compared to a waitlist control [15] but
this model is unlikely to be sustainable. Two studies found a
single-session intervention to be no better than usual care
[12,14]. Since these, Papas et al (2020) [16], in a large RCT
(n = 614) in Kenya (n = 614), found a culturally adapted 6-
session group CBT intervention delivered by paraprofessional
counsellors to be superior to a Healthy Lifestyles education
intervention in reducing percent drinking days and mean
drinks per day at nine-month follow-up. Zimbabwe has a dis-
proportionately high burden of HIV of 1.3 million PLWH in a
population of 16 million and over six litres of alcohol con-
sumption per capita, yet no systematic screening of alcohol
use in PLWH is routinely undertaken at HIV care clinics
[17,18]. Interventions for alcohol use in Zimbabwe should
include screening for regular and recent alcohol consumption
as a risk factor for HIV acquisition in HIV counselling and
testing settings. Screening and counselling for alcohol use
have the potential to improve HIV treatment outcomes in
PLWH who have an AUD in these settings.
We have previously described the adaptation and prelimi-
nary testing of an intervention based on MI and simple CBT
for AUD in an HIV care clinic in Zimbabwe [19,20]. Forma-
tive qualitative work identified stigma and the time commit-
ment required by patients as being the main impediments to
uptake [21]. Furthermore, our pilot and feasibility RCT pro-
vided preliminary evidence that interventions targeting AUD
could be effectively delivered by nurses; could reduce alcohol
use and improve immunological parameters in PLWH [22]. In
studies of PLWH, quality of life and functioning have been
shown to be both predictors and outcomes of virological
suppression and should be assessed [23-25]. Our aim here
was to compare an adapted nurse-delivered intervention
based on MI and CBT techniques (MI-CBT) with nurse-deliv-
ered brief psychoeducation based on the mhGAP IG. We
hypothesized that MI-CBT would be significantly superior to
EUC in improving both primary and secondary outcomes.
We aimed to assess changes in AUD, viral load, functioning
and quality of life.
2 | METHODS
2.1 | Setting and sampling
In Zimbabwe, HIV care has been decentralized outside ter-
tiary hospitals to increase access to antiretroviral therapy.
Nationally, there are 109 medium-sized facilities comprising 7
provincial, 47 district and 25 church-related hospitals and 30
large urban primary care polyclinics. In order to generate a
representative sample, clusters were stratified by the number
of patients registered for HIV care. Based on these stratifica-
tion criteria, 16 facilities were randomly selected for the trial:
two provincial hospitals, six district hospitals, five church-re-
lated hospitals and three polyclinics. We used a computer-gen-
erated randomization schedule to allocate clusters to MI-CBT
and EUC arms in a 1:1 ratio.
2.2 | Sample size
The sample size calculation was based on a meta-analysis of
brief interventions for alcohol use disorders [26] on literature
guiding the estimation of sample size for cluster RCT [27] and
on data obtained from our pilot study [19]. The total sample
size of 16 clusters, 8 clusters per arm, each with 15 partici-
pants enrolled per cluster giving a total sample of 240 (120
per arm), provided 80% power to detect a mean score differ-
ence of 2.5 on the AUDIT (with precision of 0.45) between
the treatment conditions (with a standard deviation within a
cluster of 4), assuming an intra-cluster correlation of 0.02 and
taking into account a design effect of 1.56 and an attrition rate
of 30% Blinding. Registered general nurses who provided the
treatments and the principal investigators were not blinded to
the treatment arms. However, the graduate-level research
assistants who recruited participants and performed baseline
and outcome measures were blinded to the treatment arms.
2.3 | Participants
PLWH with an AUD, on combination antiretroviral therapy,
were recruited at HIV clinics. Inclusion criteria were as fol-
lows: at least 18 years of age; on antiretroviral therapy for at
least three months; score of ≥6 (for women) or ≥7 (for men)
on the Alcohol Use Identification Test (AUDIT) and free of
cognitive impairment as assessed with the International HIV
Dementia Scale (score more than 10).
2.4 | Recruitment
We developed a computerized data of all adults attending
HIV care at the 16 facilities. For each facility, 450 adults were
randomly selected to be contacted for possible participation.
Trained recruiters contacted individuals at the facilities by
phone or in person with assistance from outreach services at
the facilities. Those with any reported alcohol use were invited
to screen for the study using the AUDIT. Those with AUDIT
scores above the cut point and meeting all eligibility criteria
were enrolled. The target was 15 participants per facility.




Participants received MI-CBT, which has been previously
piloted in Zimbabwe [19]. Based on our past feasibility study,
we split the original four sessions into two to make the con-
tent more deliverable for nurses within their usual consulta-
tion sessions, thus extending the intervention to eight
sessions. The components of MI-CBT were derived from Pro-
ject MATCH Motivational Enhancement Therapy (MET) and
Cognitive Behavioural Therapy (CBT) manuals [28,29]. The
intervention comprised up to 10 sessions with each session
lasting 45 to 60 minutes. Session 1 included personalized
feedback on the participants’ AUDIT score with education
about the interpretation of different AUDIT cut-off scores.
Personalized feedback is simple and limited to information
giving – it involves telling the person what their AUDIT score
is and then explaining what that signifies, based on the
WHO AUDIT guide. Session 1 also included feedback on the
viral load, explaining the implications of a high viral load.
Education was then provided about the link between AUDIT
score and viral load. The nurse worked with participants to
set their own alcohol reduction goals and their own HIV
treatment goals. Session 2 included exploration of partici-
pants’ reasons for alcohol use, and assessment of their cur-
rent stage of change. In session 2, the nurse reinforced the
link between alcohol use and viral load. Session 2 included a
review of participants’ alcohol reduction goals and their HIV
treatment goals. In most cases, the goal was reduction rather
than abstinence. Finally, in Session 2, participants’ life goals
were elicited. Session 3 included a review of participants’
alcohol reduction goals, their HIV treatment goals and their
life goals. Session 3 also included a discussion of the pros
and cons of changing alcohol use. Session 4 included a
review of participants’ alcohol reduction goals, their HIV
treatment goals and their life goals, and included brainstorm-
ing around the difficulties in moving towards each of the
goals. As participants moved towards change, Session 4 fur-
ther included advice about dealing with situations where
they would be at risk of excessive consumption. In the Zim-
babwean context; this included such techniques as drinking
alcohol slowly, being the last person to finish their alcoholic
drink, drinking water instead of alcohol, eating food before
consuming any alcohol and alternating alcoholic drinks with
drinking water. Session 5 included a review of participants’
alcohol reduction goals, their HIV treatment goals and their
life goals, and brainstorming around difficulties in moving
towards each of the goals. Session 5 also included a discus-
sion of situations in which drinking was unavoidable and also
sought to identify triggers for relapse. Session 6 included a
discussion on dealing with the challenges around HIV treat-
ment, such as running out of antiretroviral therapy, HIV com-
plications and coping with life. Sessions 7 and 8 included
planning for the future, anticipating challenges, and discussing
further treatment for HIV and/or alcohol-related difficulties,
as needed. For each session attended, participants were
reimbursed for their bus fare and given $3 compensation in
line with local IRB standards. We added two sessions for
personalized feedback about personal goals on alcohol use
and HIV treatment outcomes at three and six months, bring-
ing the total maximum number of sessions to ten.
2.6 | Control
Participants received enhanced usual care group (EUC) com-
prising care based on the alcohol-use module of the WHO
Mental Health Gap Intervention guide (WHO mhGAP IG)
[30]. The WHO mhGAP IG has previously been used in other
studies as an active control [11]. The EUC consisted of indi-
vidual feedback on participants’ AUDIT score, their viral load
and CD4 count results and psychoeducation on safe drinking.
This lasted two to three hours, divided into one or two ses-
sions. We added two sessions to provide personalized feed-
back on alcohol use and HIV treatment effectiveness at three
and six months.
2.7 | Supervision
Registered general nurses received supervision from BD who
is a trained master’s level mental health nurse. Supervision
was both provided in person and over the phone. The sessions
lasted between 45 to 70 minutes depending on the individual
intervention staff needs. The supervision sessions occurred
between session 1 and 4, then at month 3 and 6. Specific
components of supervision included assessment of compliance
with the intervention protocol as well as administrative com-
pliance (i.e. matching of participant records with the interven-
tion nurse records, duration of sessions as obtained on the
audio-tapes, matching participant sign-offs for reimbursements
with receipts and staff records). Where there were protocol
or administrative violations, corrective measures were taken.
2.8 | Outcomes
The primary outcome was a change in AUDIT score from
baseline to six months. Secondary outcomes were the change
in viral load, CD4 count, functionality, as measured by the
World Health Organisation Disability Schedule 2.0 (WHODAS
2.0) score and quality of life as measured by the World Health
Organisation Quality of Life HIV (WHOQoL HIV) score from
baseline to six months.
2.9 | Measures
2.9.1 | Alcohol use
The Alcohol Use Disorders Identification Test (AUDIT) is a
ten-question scale which can be used as an interview or as a
self-report tool. It was developed by the WHO to screen
patients for possible unhealthy alcohol consumption for use in
primary care settings [31,32].The AUDIT has three questions
on alcohol consumption, three questions on drinking behaviour
and dependence and four questions on the consequences or
problems related to drinking [33-35]. Although the AUDIT has
not been validated in Zimbabwe, several studies have utilized
the AUDIT as an instrument to assess alcohol use in various
communities including Zimbabwe [36-38]. A recent systematic
review found a variety of cut-off points being used [39]. The
AUDIT has been found to perform well in detecting hazardous
drinking at scores from >3 to >5; for harmful drinking from
>5 to >16; and for dependent drinking from >7 to >24 [40],
with differential cut-off points for females and males [41]. In
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this study we used a cut-off point of 6 for females and 7 for
males, based on studies of harmful drinking and hazardous
drinking [39]. We chose this slightly lower cut-off point,
informed by the literature, on the grounds that the negative
effects of alcohol on physiologic damage are worse in people
living with HIV [6] than those not infected and because our
pilot study suggested that locally brewed drinks are high in
alcohol content in Zimbabwe [22]. Countries vary as to the
unit or amount of alcohol in a standard drink [42], but this
information is not yet available for Zimbabwe.
2.9.2 | Adherence to HIV treatment
Adherence to HIV treatment was measured as a percentage
of scheduled visits for collection of medication refills in the
past three months which was collated from routine pharmacy
records [44]
2.9.3 | Viral Load and CD4
Viral load (copies/mL) and CD4 count (absolute number of
cells per cubic liter) were measured from whole blood at
baseline and at six months (i.e. at the completion of the fol-
low-up period). Absolute values for viral load were log-trans-
formed for the analysis due to skewness of the data. A
suppressed viral load was defined as <40 copies/mL on the
COBAS AmpliPrep platform. All samples were analyzed by
the University Of Zimbabwe Department Of Medicine Infec-
tious Disease Laboratory.
2.9.4 | Disability
The World Health Organisation Disability Assessment Sched-
ule-2.0 (WHODAS 2.0) was used to assess for functional dis-
ability. This is a short, face-valid measure of self-reported
disability, developed to measure disease burden across all psy-
chiatric and medical diseases, across populations and cultures
[43]. The WHODAS 2.0 incorporates 6 domains: cognition,
mobility, self-care, getting along, life activities and participation
[43]. Although the WHODAS 2.0 has not been validated in
Zimbabwe, it has been used with PLWH HIV patients in SSA
[43].
2.9.5 | Quality of life
The WHO Quality of Life in HIV (WHOQoL HIV) was used to
assess quality of life [44]. This tool has six domains that
include physical, psychological, level of independence, social
relationships, environment and spirituality domains. Although
the WHOQoL has not been validated in Zimbabwe, the tool
has been used in the region [44].
2.9.6 | Procedure
Registered general nurses (RGNs) were trained, with one
team providing training in MI-CBT and another team provid-
ing training in the EUC. The training included PowerPoint pre-
sentations, quizzes and role-playing. Training took place at the
clinics which allowed the RGNs to integrate the training into
their usual schedule. Training in the MI-CBT took a full day of
seven hours, while training in the EUC took three hours. Each
participant was allocated to a specific nurse who delivered the
full course of treatment. Appointments were scheduled to
avoid disruption of normal clinic activities. RGNs were com-
pensated for their time (at US $5 per session) to deliver the
therapies.
2.9.7 | Fidelity
Treatment sessions were recorded by hand, and approximately
10% of the sessions were audio-recorded after consent was
given, at least one session per client. Audio-recorded sessions
were used to provide feedback to the nurses to improve their
competencies in the interventions and to help maintain the
fidelity to treatment delivery. The two study teams visited
each clinic for two separate days during the first three months
of the study to provided supervision sessions.
2.9.8 | Ethics
All procedures involving human subjects/patients were
approved by Stellenbosch Health Research Ethics Committee
(HREC) and the Medical Research Council of Zimbabwe
(MRCZ) - approval: (SI/10/14/222) and (A/1936). The clinical
trial registration number is PACTR201509001211149 – regis-
tered with https://pactr.samrc.ac.za/.
2.9.9 | Statistical analysis
All participants were included in the analysis of primary and
secondary outcomes. For baseline assessments, descriptive
statistics including means and their standard deviations, medi-
ans and their interquartile ranges were used. Chi2 were used
for categorical and t-tests were used for numerical variables.
To account for the stratified cluster trial design, a random-ef-
fects analysis-of-covariance model was utilized with fixed
effects for baseline value and treatment arm, a random effect
for treatment arm nested in clinic and a random intercept rel-
ative to the regression component of the ANCOVA model of
the six-month level as a function of the baseline value within
cluster. Independent t-tests were used to compare the base-
line characteristics of the two groups. Analyses were under-
taken using SAS 9.4 [45]. All tests were two-sided with an
alpha = 0.05. All outcome measures (AUDIT score, WHODAS,
WHOQoL, viral loads and CD4) were unavailable for all partic-
ipants lost to follow-up at six months regardless of arm. Miss-
ing data were treated as missing at random. Potential
covariates were not predictive of missingness, hence
approaches such as propensity score adjustments were not
feasible or even necessarily needed. We believe the missing at
random assumption is reasonable with respect to no real pat-
terns of missingness in the dataset as a function of potential
predictors.
3 | RESULTS
Five hundred and twenty-nine patients were eligible on the
basis of their AUDIT score. However, 190 did not meet the
other study criteria and 105 declined to participate. Two
hundred and thirty-four participants were recruited. Figure 1
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is a consort diagram for the study. There were 108 (46%)
participants in the MI-CBT group and 126 (54%) participants
in the EUC group. Participants were recruited from Novem-
ber 2016 to November 2017 and followed through to May
2018. Cluster sizes by clinic ranged from n = 5 to n = 21
with a median cluster size of n = 15. We retained 175
(75%) of participants at six months (83% in MI-CBT and
67% in EUC) with no statistically significant difference in loss
to follow-up between the arms (p = 0.196). Two participants
died of conditions related to HIV, and 57 (24%) could not
be traced due to relocating from their place of residence.
For the six-month comparisons there was therefore roughly
a 25% missing rate due to loss of follow-up and across vari-
ables. Therefore, a total of 918 (85%) of sessions were deliv-
ered in the MI-CBT arm and 351 (70%) delivered to the
EUC arm. The number of sessions delivered to the two arms
was not statistically significantly different between the arms
(p = 0.49; Pearson correlation of 0.86).
Missing data at six months are primarily due to attrition.
The planned attrition rate was 30%. The actual missing values
were consistent across all measures and were 29% missing-
ness due to attrition. There was not a specific variable that
was differentially missing at a higher rate above 29%. Missing
data due to causes other than attrition were negligible. Miss-
ingness due to causes other than attrition ranged from 0% to
3% across the set of six-month endpoints. Differential missing-
ness between the two treatment arms, was not significant.
Characteristics of the sample, broken down by trial arm, are
shown in Table 1. More participants in the MI-CBT were in
paid work compared to those in the EUC (p = 0.03). The med-
ian number of sessions was 9 (range 4 to 10) in the MI-CBT
arm and 4 (range 3 to 4) in the EUC arm.
Figure 1. Consort flow diagram for cluster randomised trial.
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3.1 | Baseline assessments
At baseline, the mean AUDIT score for the MI-CBT arm was
14.9 (SD 6.3) and for the EUC arm it was 14.7 (SD 6.2)
(p = 0.81). The MI-CBT arm had a higher log10 viral load 1.86
(SD 0.79) than the EUC arm 1.48 (SD 0.68) although this dif-
ference was not statistically significant (p = 0.13). Baseline
CD4 count was similar between the arms with the MI-CBT at
338.7 (SD 234.6) and the EUC at 338.7 (SD 234.6)
(p = 0.37). There were no between-group differences in mean
WHODAS 2.0 or WHOQOL scores.
3.2 | Fidelity
Use of intervention manual, recording of sessions both as audio-
tapes and notes, and use of participants’ intervention experience
cards were the tools for maintaining intervention fidelity.
Review of the 118 (10%) of sessions that were audio-taped was
compared with participants’ notes, as planned. The review of the
audio-tapes, intervention notes and participants’ experience
showed fidelity to MI-CBT at 86% and 79% for EUC.
3.3 | Primary outcome
3.3.1 | AUDIT score
As shown in Table 2, at six months there was a statistically
significant difference in AUDIT score between MI-CBT and
EUC arms, with a mean difference (95% CI) of 3.09 (4.53;
0.01), p = 0.05). At Baseline, both participants in the MI-
CBT and EUC arm had mean AUDIT, scores of around 14.8.
At six-month post-intervention, participants in the MI-CBT
arm had a mean score of 8.75, whereas participants in the
EUC arm had mean scores of 11.61. Both arms had a statisti-
cally significant pre-post reduction in AUDIT score at follow-
up compared to baseline: MI-CBT mean difference (95% CI)
6.15 (6.32; 6.00) p < 0.001 and EUC mean difference
(95 % (CI) 3.09 (3.21; 2.93) p < 0.001 arms.
3.4 | Secondary outcomes
3.4.1 | Viral load
As shown in Table 2, there was a statistically significant
reduction in viral load at six months, compared to baseline, or
both with the MI-CBT log mean difference (95% log (CI)
0.77 (1.08; 0.15) p < 0.001) and the EUC log mean dif-
ference (95% (CI) log  0.40 (1.02; 0.11); p = 0.041) as
shown in Table 2. However, the mean difference between MI-
CBT and EUC was not statistically significant (95% (CI)
log  0.37 (0.45; 0.12; p = 0.46) at six months. The percent-
age of the detectable viral load at baseline was 28.70% (>40
copies per mL). The drop we reported in viral load is very
encouraging and is consistent with a meta-analysis of studies
of interventions aiming to improve adherence in HIV which
showed that participants who received an intervention were
Table 1. Characteristics of participants in the two treatment arms, MI-CBT and EUC
Variable sample (%)
MI-CBT
n = 108 [46]
EUC
n = 126 [53]
p-valueM (SD) M (SD)
Mean age (SD) 43.6 (9.4) 43.0 (9.3) 0.15
Mean number of years in school (SD) 10.8 (3.2) 10.2 (2.9) 0.69
Gender (%) n (%) n (%)
Female 17 (15.7) 33 (26.2) 0.11
Male 91 (84.3) 93 (73.8) 0.36
Marital status (%)
Married 71 (65.7) 75 (59.5) 0.47
Divorced 11 (6.5) 12 (9.5) 0.23
Single 10 (9.3) 24 (19.1) 0.58
Widowed 7 (6.5) 8 (6.4) 0.21
Co-habiting 9 (8.3) 7 (5.6) 0.63
Main work status (%)
Paid work 38 (30.2) 27 (25.0) 0.03
Self-employed 60 (47.6) 66 (61.1) 0.15
Non-paid work 3 (2.4) 4 (3.7) 0.21
Student 3 (2.4) 5 (4.6) 0.11
Keeping house 4 (3.2) 3 (2.8) 0.27
Retired 2 (1.6) 1 (0.9) 0.02
Unemployed 16 (14.8) 2 (1.5) 0.07
Duration on antiretroviral therapy 5.36 (2.0) 5.12 (2.0) 0.72
ART appointment adherence in previous 3 months 87% 89% 0.56
EUC, Enhanced Usual Care.
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1.25 times as likely to achieve an undetectable VL as partici-
pants in a control arm. At baseline slightly more in the MI-
CBT arm than in the EUC arm were suppressed (37.7% vs.
28.7%). At follow-up, 89% in the MI-CBT arm and 86.4% had
virological suppression.
3.4.2 | CD4
At six months there was no statistically significant change in
CD4 count for either arm and no difference between arms:
MI-CBT mean difference (95% (CI) 29.88 (96.28; 36.50)
p = 0.38); EUC mean difference (95% (CI) 35.92 (21.57;
93.41) p = 0.22); Effect size mean difference (95% (CI) 31.
55 (114.03; 50.93) p = 0.45.
3.4.3 | Functionality
There was a statistically significant improvement in functional-
ity for both interventions: mean difference (95% (CI) 0.95
(0.10; 1.80); p = 0.029 and EUC mean difference (95% (CI)
1.25 (0.39; 2.52) p = 0.01 arms, but group differences were
not significant: mean difference (95% (CI) 0.3 (0.07; 1.67)
p = 0.67.
3.4.4 | Quality of life
Quality of life improved significantly in both arms between
three and six months: MI-CBT MD (95 % CI) 13.63
(17.05; 10.21), p < 0.001; EUC MD (95 % (CI) 12.21
(14.71; 9.72) p < 0.001. However, there were no statisti-
cally significant between-group differences MD 95% (CI)
1.22 (4.85; 2.41); p = 0.51, as shown in Table 2.
4 | DISCUSSION
This is one of very few randomized clinical trials in a low-in-
come African country in people living with HIV and co-existing
alcohol use disorders to show that interventions task-shared
to general nurses led to declines in alcohol use, general func-
tion and viral load. This was the case for participants who
received an average of nine-sessions of a psychological
Table 2. Primary and secondary outcomes in the active arm (MI-CBT) compared to the EUC arm
MI-CBT EUC
Primary outcomes
AUDIT score M (SD)
Baseline AUDIT score 14.89 (6.31) 14.74 (6.22)
6-month Mean Difference [95% CI] 6.15 [6.32; 6.00]*** 3.09 [3.21; 2.93]***
Difference between MI-CBT and EUC [95% CI] 3.09 [4.79; 1.23]*
Secondary outcomes
Viral load M (SD)
Baseline viral load log10 1.86 (0.79) 1.48 (0.68)
6-month mean difference [95% CI] 0.77 [1.08; 0. 23]* 0.40 [1.02; 0.11]*
Difference between MI-CBT and EUC [95% CI] 0.37 [0.45;0.12]
Proportion with viral load undetectable %
Baseline proportion with viral load undetectable 28.72 37.71
6-month mean difference [95% CI] 0.77 [1.08; 0. 23]*** p = 0.29 0.40 [1.02; 0.11]*
p = 0.12
Mean difference between MI-CBT and EUC [95% CI] 0.37
CD4 M (SD)
Baseline CD4 Count 338.7 (234.58) 442.6 (236.81)
6-month mean difference [95% CI] 29.93 [96.3;36.5] 35.91 [1.6;93.4]
Mean difference between MI-CBT and EUC [95% CI] 65.8 (114.0;50.9)
WHODAS M (SD)
Baseline WHODAS score 14.64 (2.98) 16.19 (4.57)
6-month mean difference [95% CI] 0.95 [0.10;1.80]* 1.25 [0.39;2.52]**
Mean difference between MI-CBT and EUC [95% CI] 0.3 [0.07;1.67]
WHOQOL M (SD)
Baseline WHOQOL Score (SD) 86.33 (14.73) 84.43 (9.54)
6-month mean difference [95% CI] 13.63 [10.11;17.24]*** 12.21 [9.72;14.74]***
Mean difference between MI-CBT and EUC [95% CI] 1.22 [4.85;2.41]
AUDIT, Alcohol Use Disorders Identification Test; CI, Confidence Interval; EUC, enhanced usual care; MD, Mean Difference; SD, Standard Devia-
tion; WHODAS, World Health Organization Disability Schedule; WHOQOL, World Health Organisation Quality of Life.
*Effect size significant at the p ≤ 0.05 level; **Effect size significant at the p ≤ 0.01 level; ***Effect size significant at the p ≤ 0.001 level.
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intervention based on motivational interviewing with brief
CBT, and also for those who received a brief package of 3 to
4 sessions of psychoeducation with personalized feedback on
alcohol use. Trial results also show that the MI-CBT interven-
tion was superior in reducing alcohol use, based on the AUDIT
score, at 6-month follow-up. At baseline, both participants in
the MI-CBT and EUC arm had mean AUDIT scores of around
14.8. This was within the upper band of harmful drinking.
According to cut-off scores described by Nadkarni and col-
leagues, the mean score of 8.75 at six-month post-interven-
tion for the MI-CBT arm still indicates harmful drinking,
however at a lower end of the severity band, whereas the
mean score of 11.61 in the EUC arm indicates harmful drink-
ing, closer to the upper end of the band [39]. Based on valida-
tion of the AUDIT scale in multiple countries, the decrease in
AUDIT score we demonstrated in the MI-CBT arm suggests a
drop from a highly hazardous or even harmful level of alcohol
intake with a high risk of dependence to a level which has a
low to moderate risk of hazard and a low risk of dependence
[32]. However, in the absence of validated AUDIT cut-points
for Zimbabwe we can only make this assertion tentatively.
Our findings are in keeping with a systematic review from
2017 assessing the effect of behavioural interventions on
alcohol use in PLWH, which found a reduction in drinking
behaviour [46]. Our findings strengthen the preliminary evi-
dence from a small RCT in Kenya among HIV-outpatients,
consisting of a culturally adapted group CBT, which found a
statistically significant difference in self-reported alcohol
abstinence at 90-day follow-up [13], and from a trial of a
four-session intervention in women living with HIV in South
Africa who had heavy drinking [10]. In a follow-up study,
Papas showed CBT-based intervention to reduce mean
drinks per day and percentage drinking days thus supporting
the use of psychological interventions in alcohol use. The
drop in viral load, and the increase in those with viral sup-
pression, was not statistically significant between MI-CBT
and the EUC arms but improved from baseline in each arm
suggesting a clinically important effect of these interventions
on adherence. We may have been able to demonstrate a
stronger effect of the intervention on reducing viral load if
we had targeted this intervention at participants with base-
line viral non-suppression. By including those with viral sup-
pression we may have diluted the effects on viral load. This
RCT indicates that task-sharing can be an effective approach
for addressing AUD in PLWH. Nurses in Zimbabwe are
respected, educated and well-trained. Across SSA where
trained nurses provide HIV care, there are opportunities to
capacitate these nurses to manage mental health comorbidi-
ties, such as problematic alcohol use [21,47]. Evidence-based
interventions, such as MI-CBT for AUD, can be effectively
delivered by up-skilling existing staff [20].
One reason for our findings could be that we used many
sessions, both in the active and the EUC arms. We were influ-
enced by evidence from Project MATCH in terms of content
of the intervention and adapted this to a format that the
nurses could provide in the context within their usual clinical
sessions [29]. Another reason could be that we used personal-
ized feedback in both the MI-CBT arm and the EUC arm. Per-
sonalized feedback is described in more detail earlier but
essentially comprises telling the person their AUDIT score and
explaining what this score means in terms of risk of harm to
body organs and to risk of social harms. We were influenced
in choosing our intervention by a prior study in South Africa
which found that a three-session motivational-skills building
risk-reduction intervention in PLWH was associated with a
reduction in the use of alcohol [48]. We think the number of
sessions in our MI-CBT was reasonable given the complexity
of co-morbid AUD and HIV. Future research needs to look at
options for providing session material in groups [10,49],
although group therapy can be challenging to arrange in rou-
tine clinical settings in LMIC given distances from clinics and
transport costs. Delivery via mobile technology could be
another option given the wide use of phones in SSA, and tech-
nology has been shown to be a useful vehicle for MI-based
interventions in the US [9,50].
This cluster RCT has several limitations. First, cluster RCTs
have diminishing returns in precision and power as the size of
the cluster increases. In order to mitigate this in our trial, we
determined the number of clusters and cluster size concur-
rently. To try to limit selection bias, which is another concern
with cluster RCTs, facilities were selected through stratified
randomization and participants were randomly selected within
clusters. Individuals less easy to be contacted are likely to be
under-represented as the study funds did not allow for
researchers to visit everyone who could not be contacted by
phone or through normal clinic outreach. Second, participants
were not and could not be blinded to the allocation which
was a limitation of our study. However, the outcome assessors
were blinded to the arm of the facility. Third, our study had
differential loss to follow-up (which was, however, not statisti-
cally significant) with more participants lost in the control arm,
which is a limitation. The loss to follow-up was greater in the
EUC arm than in the MI-CBT arm. The effect of the MI-CBT
intervention on reduction in alcohol use and in viral load was
greater than the effect of the EUC intervention, although this
was only significant at the 0.05 level for alcohol use and was
non-significant in the case of viral load. If the follow-up had
been more equal, we might have been able to demonstrate a
stronger effect of the intervention on alcohol use and even on
viral load. Given that the loss to follow-up was greater in the
EUC arm it is possible that the MI-CBT intervention was
more effective than EUC in promoting better engagement in
care. Fourth, a limitation of our study is that alcohol use was
measured with the AUDIT which is a self-report questionnaire
and subject to social desirability bias [51]. Social desirability
may have led to bias in the reporting of reduced alcohol use
in the intervention arm. We think this is unlikely to fully
explain differences between the two arms given that variables
that are not reliant on self-report, such as viral load, also
improved more in the intervention arm. Self-report methods
are considered a reliable and valid approach to measuring
alcohol consumption [52]. While future research should
include biomarkers such as phosphatidyl ethanol (PEth) it is
worth noting that in the absence of a gold standard biological
measure for alcohol it is difficult to explain discrepancies
between self-report and PEth that have been documented in
other studies [53,54]. For the 6-month comparison, there was
roughly a 25% missing rate due to loss of follow-up and
across variables. This is a limitation of the study but, as the
dropouts were random, it implies a loss of statistical power
but still valid results. The AUDIT, WHODAS and WHOQOL
have not been validated in PLWH in Zimbabwe, although they
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have been validated in other countries in SSA, and Zimbabwe
was one of the study sites in their development [32,44,55]. In
the absence of a validated AUDIT cut-off in this population,
we used cut-offs from other studies. We acknowledge that we
used a lower-cut-point than previously used levels in the gen-
eral population. The WHO guidance [31] on the use of the
AUDIT emphasizes that selection of the cut-off point should
be influenced by national and cultural standards. Data from
validation of the AUDIT advise “Scores of 6 to 7 may indicate
potential harm for groups more susceptible to the effects of
alcohol, such as young people, women, the elderly, people with
mental health problems and people on medication” [31]. We
used a lower-cut-point because of evidence that PLWH who
drink the same amount as HIV-negative people have higher
blood alcohol levels and a greater risk of liver damage;
because locally brewed alcohol drinks in common use in Zim-
babwe tend to have high levels of ethanol; because of lack of
validation of precise AUDIT cut-points in Zimbabwe; and
because alcohol consumption per capita is less across low-in-
come African countries than in the US and Europe, especially
among women [56,57]. Therefore, we chose a conservative
threshold given our population under investigation and
described drinking patterns in Zimbabwe. Research is needed
to validate cut-points for AUDIT in Zimbabwe and other low-
resource African countries as it remains unclear as to what
the decrease of the AUDIT score by 3 units means clinically
and is thus another limitation of the conclusions we can draw
from this study. A further limitation was that the cluster size
was not equal across all sites. The intention was to recruit 15
eligible participants per cluster, however, due to time and
resource constraints, including minimal study funding, in some
cases recruiters had to move onto the next facility without
having recruited 15 participants, ending up with a range of 6
to 21 per site. Another limitation is that potential participants
less easily to be contacted are likely to be under-represented
in those recruited. This study was carried out for a PhD for
the lead author (MM) and thus explains the time constraints.
Further funding and time would have allowed recruiters to
stay for longer at each site, and for researchers to visit to
screen everyone from the random sample of potential partici-
pants. Another limitation is that due to lack of funds, follow-
up was limited to six months. Examining longer term mainte-
nance effects of AUD interventions should be built into the
design of future trials.
This has important implications for practice and policy, and
for Sustainable Development Goals, suggesting that personal-
ized feedback on alcohol use could be incorporated into regu-
lar HIV follow-up for those with hazardous drinking. The MI-
CBT intervention showed that effects are maintained at six
months although the authors would want to understand the
effects of the intervention over a long period of time.
5 | CONCLUSIONS
This cluster RCT showed that an MI-CBT intervention can be
effectively implemented by non-specialist providers and led to
improvement in a number of clinical outcomes. Monetary
incentives may be given to the registered general nurses to
ease their burden of performing extra duties due to an
increased work load. A next step is the evaluation of the cost-
effectiveness of these interventions that takes the complexity
of current HIV treatment settings and current staffing into
account, and which actively involves people with lived experi-
ence of HIV and alcohol use in the design of these trials.
AUTHORS ’ AFF I L IAT IONS
1Department of Psychiatry, University of Zimbabwe, Harare, Zimbabwe; 2SUNY
University at Buffalo, Buffalo, NY, USA; 3Centre for Statistical Consultation,
Stellenbosch University, Stellenbosch, South Africa; 4Department of Medical
Laboratory Sciences, University of Zimbabwe, Harare, Zimbabwe; 5Institute of
Psychiatry, Psychology and Neuroscience, King’s College London, London, United
Kingdom; 6Department of Biostatistics and Bioinformatics, Roswell Park Com-
prehensive Cancer Center, Buffalo, NY, USA; 7SUNY University at Buffalo, Buf-
falo, NY, USA; 8Lewisham Hospital, South London and Maudsley, NHS
Foundation Trust, London, United Kingdom; 9Faculty of Medicine and Health
Sciences, Stellenbosch University, Stellenbosch, South Africa
COMPET ING INTERESTS
The authors declare that they have no competing interests.
AUTHORS ’ CONTR IBUT IONS
MM and SS conceived the study and developed the concept. MM, SS and MA
developed the protocol of the study. AC, DC and SR critically reviewed the pro-
tocol and MK and AH developed the data analysis plan and carried out the data
analysis. MM, SS, MA BD, MD, WM and TM developed the interventions. GDM
and DTZ participated in the development of the manuscript. MM and MA wrote
the first and second drafts together. All authors reviewed the manuscript and
approved its submission.
ABBREV IAT IONS
ACASI, Audio Computer Assisted Self-Interview; AUD, Alcohol Use Disorders;
AUDIT, Alcohol Use Disorders Identification Test; EUC, Enhanced Usual Care;
LMIC, Low-and Medium-Income Countries; MI-CBT, Motivational Interviewing –
Cognitive Behavioural Therapy; PLWH, People living with HIV; RCT, Random-
ized Controlled Trial; SSA, Sub-Saharan Africa; WHO mhGAP IG, World Health
Organization mental health gap intervention guide?; WHODAS, World Health
Organisation Disability Assessment Schedule; WHOQOL, World Health Organi-




Research reported in this publication was supported by the Fogarty Interna-
tional Center (Office of The Director, National Institutes of Health (OD),
National Institute of Nursing Research (NINR), National Institute of Mental
Health (NIMH), National Institute of Dental & Craniofacial Research (NIDCR),
National Institute of Neurological Disorders and Stroke (NINDS), National
Heart, Lung and Blood Institute (NHLBI), Fogarty International Center (FIC) of
the National Institutes of Health, award D43 TW010137, the DELTAS Africa
Initiative [DEL-15-01]. The DELTAS Africa Initiative is an independent funding
scheme of the African Academy of Sciences (AAS)’s Alliance for Accelerating
Excellence in Science in Africa (AESA) and supported by the New Partnership
for Africa’s Development Planning and Coordinating Agency (NEPAD Agency)
with funding from the Wellcome Trust [DEL-15-01] and the UK government,
Grant Number D43TW010313-02S3 from the National Institutes of Health,
Fogarty International Center and the National Research Founding through
Funding to Professor Soraya Seedat SARChi Research Chairs. The study also
received support from King’s College London Partnership Fund for viral load
testing. The content is solely the responsibility of the authors and does not nec-
essarily represent the official views of the Fogarty International Center or the
National Institutes of Health, the DELTAS Africa Initiative, King’s College Lon-
don and the National Research Foundation SARChi Research Chairs. As a FIC
scholar, MM also received research training from the Clinical and Translational
Science Institute (award UL1TR001412).




1. Rehm J, Gmel GE Sr, Gmel G, Hasan OSM, Imtiaz S, Popova S, et al. The
relationship between different dimensions of alcohol use and the burden of dis-
ease-an update. Addiction (Abingdon, England). 2017;112(6):968–1001.
2. Shuper PA, Joharchi N, Monti PM, Loutfy M, Rehm J. Acute alcohol con-
sumption directly increases HIV transmission risk: a randomized controlled
experiment. J Acquir Immune Defic Syndr. 2017;76(5):493–500.
3. Sonderup MW, Wainwright H, Hall P, Hairwadzi H, Spearman CW. A clinico-
pathological cohort study of liver pathology in 301 patients with human immun-
odeficiency virus/acquired immune deficiency syndrome. Hepatology. 2015;61
(5):1721–9.
4. Canan CE, Lau B, McCaul ME, Keruly J, Moore RD, Chander G. Effect of
alcohol consumption on all-cause and liver-related mortality among HIV-infected
individuals. HIV Med. 2017;18(5):332–41.
5. UNAIDS. Treatment cascade - progress towards 90–90-90 targets. 2019.
6. Duko B, Ayalew M, Ayano G. The prevalence of alcohol use disorders among
people living with HIV/AIDS: a systematic review and meta-analysis. Sub Abuse
Treat Prev Policy. 2019;14(1):52.
7. Nouaman MN, Vinikoor M, Seydi M, Ekouevi DK, Coffie PA, Mulenga L, et al.
High prevalence of binge drinking among people living with HIV in four African
countries. J Int AIDS Soc. 2018;21:e25202.
8. Kahler CW, Pantalone DW, Mastroleo NR, Liu T, Bove G, Ramratnam B,
et al. Motivational interviewing with personalized feedback to reduce alcohol
use in HIV-infected men who have sex with men: a randomized controlled trial.
J Consult Clin Psychol. 2018;86(8):645–56.
9. Aharonovich E, Stohl M, Cannizzaro D, Hasin D. HealthCall delivered via
smartphone to reduce co-occurring drug and alcohol use in HIV-infected adults:
a randomized pilot trial. J Subst Abuse Treat. 2017;83:15–26.
10. Zule W, Myers B, Carney T, Novak SP, McCormick K, Wechsberg WM.
Alcohol and drug use outcomes among vulnerable women living with HIV:
results from the Western Cape Women’s Health CoOp. AIDS Care. 2014;26
(12):1494–9.
11. WHO. mhGAP Intervention Guide. Mental Health Gap Action Programme.
Version 2.0. 2016.
12. Wandera B, Tumwesigye NM, Nankabirwa JI, Mafigiri DK, Parkes-Ratanshi
RM, Kapiga S, et al. Efficacy of a single, brief alcohol reduction intervention
among men and women living with HIV/AIDS and using alcohol in Kampala,
Uganda: a randomized trial. J Int Assoc Provid AIDS Care. 2017;16(3):276–85.
13. Papas RK, Sidle JE, Gakinya BN, Baliddawa JB, Martino S, Mwaniki MM,
et al. Treatment outcomes of a stage 1 cognitive-behavioral trial to reduce alco-
hol use among human immunodeficiency virus-infected out-patients in western
Kenya. Addiction. 2011;106(12):2156–66.
14. Huis in ‘t Veld D, Ensoy-Musoro C, Pengpid S, Peltzer K, Colebunders R.
The efficacy of a brief intervention to reduce alcohol use in persons with HIV in
South Africa, a randomized clinical trial. PLoS One. 2019;14:e0220799.
15. Omeje JC, Otu MS, Aneke AO, Adikwu VO, Nwaubani OO, Chigbu EF,
et al. Effect of rational emotive health therapy on alcohol use among com-
munity-dwelling, HIV-POSITIVE Patients. Medicine (Baltimore). 2018;97:
e11688.
16. Papas RK, Gakinya BN, Mwaniki MM, Lee H, Keter AK, Martino S, et al. A
randomized clinical trial of a group cognitive–behavioral therapy to reduce alco-
hol use among human immunodeficiency virus-infected outpatients in western
Kenya. Addiction. 2020. https://doi.org/10.1111/add.15112
17. UNAIDS. UNAIDS 2016 Estimates. 2016. [cited 2019 July 17]. Available
from: http://aidsinfo.unaids.org/
18. World Health Organisation. Global status report on alcohol and health
2018. 2019.
19. Madhombiro M, Dube-Marimbe B, Dube M, Chibanda D, Zunza M, Rusaka-
niko S, et al. A cluster randomised controlled trial protocol of an adapted inter-
vention for alcohol use disorders in people living with HIV and AIDS: impact on
alcohol use, general functional ability, quality of life and adherence to HAART.
BMC Psychiatry. 2017;17(1):44.
20. Madhombiro M, Musekiwa A, January J, Chingono A, Abas M, Seedat S.
Psychological interventions for alcohol use disorders in people living with HIV/
AIDS: a systematic review. Syst Rev. 2019;8(1):244.
21. Madhombiro M, Marimbe-Dube B, Dube M, Kaiyo-Utete M, Paradzai A,
Chibanda D, et al. Perceptions of alcohol use in the context of HIV treatment: a
qualitative study. HIV AIDS (Auckl). 2018;10:47–55.
22. Madhombiro M, Dube B, Dube M, Zunza M, Chibanda D, Rusakaniko S,
et al. Intervention for alcohol use disorders at an HIV care clinic in Harare: a
pilot and feasibility study. Addict Sci Clin Pract. 2019;14(1):16.
23. Liu C, Johnson L, Ostrow D, Silvestre A, Visscher B, Jacobson LP. Predictors
for lower quality of life in the HAART era among HIV-infected men. J Acquir
Immune Defic Syndr. 2006;42(4):470–7.
24. Airoldi M, Zaccarelli M, Bisi L, Bini T, Antinori A, Mussini C, et al. One-pill
once-a-day HAART: a simplification strategy that improves adherence and qual-
ity of life of HIV-infected subjects. Patient Prefer Adherence. 2010;4:115–25.
25. Ghiasvand H, Waye KM, Noroozi M, Harouni GG, Armoon B, Bayani A.
Clinical determinants associated with quality of life for people who live with
HIV/AIDS: a Meta-analysis. BMC Health Serv Res. 2019;19(1):768.
26. Moyer A, Finney JW, Swearingen CE, Vergun P. Brief interventions for alco-
hol problems: a meta-analytic review of controlled investigations in treatment-
seeking and non-treatment-seeking populations. Addiction. 2002;97(3):279–92.
27. Killip S, Mahfoud Z, Pearce K. What is an intracluster correlation coeffi-
cient? Crucial concepts for primary care researchers. Ann Family Med. 2004;2
(3):204–8.
28. MATCH Group. Matching alcoholism treatments to client heterogeneity: pro-
ject MATCH posttreatment drinking outcomes. J Stud Alcohol. 1997;58(1):7–29.
29. MATCH Group. Matching alcoholism treatments to client heterogeneity:
Project MATCH three-year drinking outcomes. Alcohol Clin Exp Res. 1998;22
(6):1300–11.
30. WHO. mhGAP Mental Health Gap Action Programme: scaling up care for
mental, neurological and substance use disorders. Geneva: World Health Organ-
isation; 2010.
31. Babor TF, Higgins-Biddle JC, Saunders JB, Monetiro MG.The Alcohol Use
Disorders Identification Test - Guidelines for Use in Primary Care. World Health
Organization Department of Mental Health And Substance Depndence. 2001; 2.
32. Saunders J, Aasland O, Babor T, de la Fuente J, Grant M. Development of
the alcohol use disorders identification Test (AUDIT): WHO collaborative pro-
ject on early detection of persons with harmful alcohol consumption–II. Addic-
tion. 1993;88(6):791–804.
33. Abiodun OA. Alcohol-related problems in primary care patients in Nigeiia.
Acta Psychiatr Scand. 1996;93(4):235–9.
34. Bensley KM, Fortney J, Chan G, Dombrowski JC, Ornelas I, Rubinsky AD,
et al. Differences in receipt of alcohol-related care across rurality among va
patients living with HIV with unhealthy alcohol use. J Rural Health. 2019;35
(3):341–53.
35. Gureje O, Obikoya B. Somatization in primary care: pattern and correlates
in a clinic in Nigeria. Acta Psychiatr Scand. 1992;86(3):223–7.
36. Chinyadza E, Moyo IM, Katsumbe TM, Chisvo D, Mahari M, Cock DE, et al.
Alcohol problems among patients attending five primary health care clinics in
Harare city. Cent Afr J Med. 1993;39(2):26–32.
37. Acuda SW, Sebit MB. Prevalence of psychoactive substance use among psy-
chiatric in-patients in Harare, Zimbabwe. Cent Afr J Med. 1997;43(8):226–9.
38. Sebit MB, Tombe M, Siziya S, Balus S, Nkomo SD, Maramba P. Prevalence
of HIV/AIDS and psychiatric disorders and their related risk factors among
adults in Epworth, Zimbabwe. East Afr Med J. 2003;80(10):503–12.
39. Nadkarni A, Garber A, Costa S, Wood S, Kumar S, MacKinnon N, et al.
Auditing the AUDIT: A systematic review of cut-off scores for the Alcohol Use
Disorders Identification Test (AUDIT) in low- and middle-income countries.
Drug Alcohol Depend. 2019;202:123–33.
40. Nadkarni S, Genberg B, Galarraga O. Microfinance interventions and HIV
treatment outcomes: a synthesizing conceptual framework and systematic
review. AIDS Behav. 2019;23(9):2238–52.
41. Conigrave K, Hall W, Saunders J. The AUDIT questionnaire: choosing a cut-
off score. Addiction. 1995;90(10):1349–1356.
42. Bloomfield GS, Khazanie P, Morris A, Rabadan-Diehl C, Benjamin LA, Mur-
doch D, et al. HIV and non-communicable cardiovascular and pulmonary dis-
eases in low- and middle-income countries in the ART era: what we know and
best directions for future research. JAIDS. 2014;67(Suppl 1):S40–53.
43. €Ust€un B, Kostanjse N, Rehm J, Kennedy C, Jordan JE, Saxena S, et al.
Developing the World Health Organization disability assessment schedule 2.0.
Bulletin of the World Health Organisation. 2010;88(11):797–876.
44. World Health Organisation. WHOQOL-HIV for quality of life assessment
among people living with HIV and AIDS: results from the field test. AIDS Care.
2004;16(7):882–9.
45. Statistic Analytical System (SAS). Statistic Analytical System 9.4: SAS Ana-
lytics Software & Solutions; 2014.
46. Scott-Sheldon LAJ, Carey KB, Johnson BT, Carey MP. Behavioral interven-
tions targeting alcohol use among people living with HIV/AIDS: a systematic
review and meta-analysis. AIDS Behav. 2017;21(S2):126–43.
47. Schall JI, Hediger ML, Zemel BS, Rutstein RM, Stallings VA. Comprehensive
Safety Monitoring of 12-Month Daily 7000-IU Vitamin D3 supplementation in
human immunodeficiency virus-infected children and young adults. JPEN J Par-
enter Enteral Nutr. 2016;40(7):1057–63.
48. Peltzer K, Davids A, Njuho P. Alcohol use and problem drinking in South
Africa: findings from a national population-based survey. Afr J Psychiatry (Johan-
nesbg). 2011;14(1):30–7.
Madhombiro M et al. Journal of the International AIDS Society 2020, 23:e25641
http://onlinelibrary.wiley.com/doi/10.1002/jia2.25641/full | https://doi.org/10.1002/jia2.25641
10
49. Weiss JW, Merrill V, Akagha K. Substance use and its relationship to
family functioning and self-image in adolescents. J Drug Educ. 2011;41
(1):79–97.
50. Hasin DS, Aharonovich E, O’Leary A, Greenstein E, Pavlicova M, Arunajadai
S, et al. Reducing heavy drinking in HIV primary care: a randomized trial of brief
intervention, with and without technological enhancement. Addiction. 2013;108
(7):1230–40.
51. Adong J, Fatch R, Emenyonu NI, Cheng DM, Muyindike WR, Ngabirano C,
et al. Social desirability bias impacts self-reported alcohol use among persons
with HIV in Uganda. Alcohol Clin Exp Res. 2019;43(12):2591–8.
52. K€allmen H, Elgan TH, Wennberg P, Berman AH. Concurrent validity of
the Alcohol Use Disorders Identification Test (AUDIT) in relation to Alco-
hol Use Disorder (AUD) severity levels according to the brief DSM-5
AUD diagnostic assessment screener. Nord J Psychiatry. 2019;73(7):397–
400.
53. Papas RK, Gakinya BN, Mwaniki MM, Keter AK, Lee H, Loxley MP, et al.
Associations between the phosphatidylethanol alcohol biomarker and self-re-
ported alcohol use in a sample of hiv-infected outpatient drinkers in Western
Kenya. Alcohol Clin Exp Res. 2016;40(8):1779–87.
54. Littlefield AK, Brown JL, DiClemente RJ, Safonova P, Sales JM, Rose ES,
et al. Phosphatidylethanol (PEth) as a biomarker of alcohol consumption in HIV-
infected young Russian women: comparison to self-report assessments of alco-
hol use. AIDS Behav. 2017;21(7):1938–49.
55. Babor TF, De La Fuente MF, Saunders JB, Grant M. AUDIT - the alcohol
use disorders identification test: guidelines for use in primary health care. Gen-
eva, Switzerland: World Health Organization; 1989.
56. Ritchie H, Roser M. Alcohol consumption. Our World In Data. 2018.
57. Cubbins LA, Kasprzyk D, Montano D, Jordan LP, Woelk G. Alcohol use and
abuse among rural Zimbabwean adults: a test of a community-level intervention.
Drug Alcohol Depend. 2012;124(3):333–9.
Madhombiro M et al. Journal of the International AIDS Society 2020, 23:e25641
http://onlinelibrary.wiley.com/doi/10.1002/jia2.25641/full | https://doi.org/10.1002/jia2.25641
11
